Browsing by Subject "meglumine antimoniate"

Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2'-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment

Oliveira, Luiz Filipe Gonçalves et al. | Date Issued: 2018

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasiand L (Viannia) braziliensis

Teixeira, Eliane de Morais et al. | Date Issued: 2008

New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: A patent landscape

Machado-Silva, Alice et al. | Date Issued: 2015

Introdução: Embora se estime que a leishmaniose cause a nona maior carga de doenças entre as doenças infecciosas individuais, ela ainda é uma das doenças mais negligenciadas em termos de desenvolvimento de medicamentos. ...

A randomized, controlled, non-inferiority, multicenter trial of systemic versus intralesional treatment with meglumine antimoniate for cutaneous leishmaniasis in Brazil

Lyra, Marcelo R et al. | Date Issued: 2023

Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum

Santos, Cristiano C. P. dos et al. | Date Issued: 2020

Browsing by Subject "meglumine antimoniate"

Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2'-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment ﻿

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasiand L (Viannia) braziliensis ﻿

New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: A patent landscape ﻿

A randomized, controlled, non-inferiority, multicenter trial of systemic versus intralesional treatment with meglumine antimoniate for cutaneous leishmaniasis in Brazil ﻿

Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum ﻿

Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2'-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasiand L (Viannia) braziliensis

New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: A patent landscape

A randomized, controlled, non-inferiority, multicenter trial of systemic versus intralesional treatment with meglumine antimoniate for cutaneous leishmaniasis in Brazil

Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum